|
|
|
| Effect of cognitive behavior combined with Escitalopram Oxalate in the treatment of depression |
| ZHENG Hui-min FENG Dong-mei DAI Juan LIANG Song-you |
| Department of Psychology,Zhongshan People′s Hospital,Guangdong Province,Zhongshan 528400,China |
|
|
|
|
Abstract Objective To explore effect of cognitive behavior combined with Escitalopram Oxalate in the treatment of depression.Methods A total of 88 patients with depression admitted to our hospital from January 2018 to May 2019 were selected.Patients admitted from January to September 2018 were set as control group(n=44,treated with Escitalopram Oxalate),while patients admitted from October 2018 to May 2019 were set as combination group(n=44,treated with cognitive behavioral therapy combined with Escitalopram Oxalate),the clinical global impression-severity of illness(CGI-SI),Hamilton depression scale(HAMD)and Hamilton anxiety scale(HAMA)scores of depression patients in two groups at different time points after treatmentwere observed.Results At 2,4 and 8 weeks treatment,the CGI-SI,HAMD and HAMA scores of patients in the combined group were lower than those in the control group;at 2,4 and 8 weeks treatment,the CGI-SI,HAMD and HAMA scores of the two groups were lower than those before treatment,the effective rate of the combination group was higher than that of the control group,and the differences were statistically significant（P＜0.05）.There was no statistically significant difference in the total incidence rate of adverse reactions between the two groups（P＞0.05）.Conclusion Cognitive behavior combined with Escitalopram Oxalate for patients with depression can effectively alleviate the severity of depression and improve depression and anxiety,which has guidance value in clinical treatmentof depression.
|
|
|
|
|
|
| [1] |
杨翠茹，刘健，刘露等.抑郁症患者认知融合和经验性回避与抑郁水平的关系[J].中国心理卫生杂志，2019，33（3）：182-186.
|
| [2] |
宗哲，刘鑫，张四喜.抗抑郁药物在综合性医院门诊中的应用情况及人群特点分析[J].中国医药，2019，14（1）：112-116.
|
| [3] |
樊落，桂莉，刘文文.认知-行为疗法对有意性急性农药中毒患者的干预效果评价[J].解放军护理杂志，2019，36（1）：51-55.
|
| [4] |
陈巧平，朱艳桥，麦思资等.舍曲林联合家庭认知治疗对重度抑郁症患者攻击行为的影响[J].广东医学，2019，40（1）：136-139，143.
|
| [5] |
世界卫生组织.疾病和有关健康问题的国际统计分类（ICD-10）[M].2版.北京：人民卫生出版社，1997：287.
|
| [6] |
刘燕朋，周进涛，连俊红.米氮平对抑郁症伴睡眠障碍患者抑郁症状、PSQI评分及睡眠结构的影响[J].实用药物与临床，2018，21（12）：1398-1401.
|
| [7] |
周立平，邹文霞，潘继红，等.基于认知行为和母婴关系疗法的围产期抑郁预防干预路径及效果评价[J].中国护理管理，2019，19（3）：373-379.
|
| [8] |
Baucom DH，Fischer MS，Worrell M，et al.Couple-based intervention for depression：An effectiveness study in the NationalHealth Service in England[J].Fam Process，2018，57（2）：275-292.
|
| [9] |
刘力，孙清雨.草酸艾司西酞普兰治疗乳腺癌伴抑郁症患者的效果[J].中国医科大学学报，2018，47（11）：1021-1024.
|
| [10] |
冯治文.艾司西酞普兰联合唑吡坦治疗抑郁症伴失眠患者的临床疗效观察[J].黑龙江医药，2019，32（3）：621-623.
|
| [11] |
张迎黎，冯飞，梁炜，等.认知行为治疗对自杀症状疗效的系统评价和meta分析[J].中国心理卫生杂志，2019，33（1）：8-14.
|
| [12] |
赵春艳，严保平，曹小会，等.氟哌噻吨美利曲辛联合草酸艾司西酞普兰治疗血液透析患者焦虑、抑郁的效果[J].中国临床研究，2018，31（5）：623-626.
|
| [13] |
张岩，曹江，徐伟杰，等.老年首发抑郁症患者临床特点及认知功能受损程度与性激素水平的变化[J].中国老年学杂志，2018，38（8）：1894-1896.
|
| [14] |
朱培俊，唐琳，杨国平.草酸艾司西酞普兰联合小剂量奥氮平治疗抑郁症的疗效与安全性观察[J].贵州医药，2018，42（8）：987-988.
|
| [15] |
张卓，闫金梅，臧明翠，等.产后抑郁社会心理因素分析及团体干预效果的病例对照研究[J].中国妇幼保健，2018，33（14）：3185-3187.
|
|
|
|
